The Centre’s decision to restrict over-the-counter sales of cough syrups is a positive step, but systemic weaknesses in India’s drug regulatory framework continue to undermine effective oversight
India’s pharma success story cannot rest on cheap generics alone. It must be backed by credibility, stronger audits, criminal liability for negligence and swift justice
